BPC-157 interacts with the nitric oxide (NO) system in a context-dependent manner, counteracting both NO-synthase inhibition and NO excess
We do not market the product as a finished pharmaceutical, and we do not provide clinical, veterinary, or human-use guidance
The shipments are always on time and the customer service is excellent
In most cases, treatment for B12 deficiency is effective, and a person will not continue to have symptoms
At the same time, we also have to acknowledge that many of these compounds still lack large-scale human clinical trials and long-term safety data
Secondly, BPC-157 has been shown to improve gut motility, which can be beneficial for individuals suffering from constipation, small intestinal bacterial overgrowth (SIBO), or other motility-related disorders